Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

RKV

Rakovina Therapeutics (RKV)

Rakovina Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:TSXV:RKV
DateTimeSourceHeadlineSymbolCompany
09/17/20244:01PMAllPennyStocks.comTargeting Cancer's Achilles Heel: AI-Driven DDR Therapies Offer HopeTSXV:RKVRakovina Therapeutics Inc
09/10/20245:53PMAllPennyStocks.comJunior Biotech Utilizes AI To Shorten Drug Discovery Timelines, Ultimately Saving LivesTSXV:RKVRakovina Therapeutics Inc
12/20/20217:35AMPR Newswire (Canada)Life Sciences Companies Investor Presentations Now Available for On-Demand ViewingTSXV:RKVRakovina Therapeutics Inc
08/17/20218:00AMPR Newswire (Canada)Rakovina Therapeutics to Present at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer TherapeuticsTSXV:RKVRakovina Therapeutics Inc
08/11/20217:00AMPR Newswire (Canada)Red Thread Ventures' portfolio company Rakovina Therapeutics'TSXV:RKVRakovina Therapeutics Inc
06/29/20213:26PMPR Newswire (Canada)Rakovina Therapeutics Announces Results from Annual General MeetingTSXV:RKVRakovina Therapeutics Inc
06/22/20218:35AMInvestorsHub NewsWireRakovina Therapeutics to Present at at The Emerging Growth Conference on June 23, 2021TSXV:RKVRakovina Therapeutics Inc
05/27/20217:00AMPR Newswire (Canada)Rakovina Therapeutics Inc. Announces First Quarter 2021 Financial Results and Provides Corporate UpdateTSXV:RKVRakovina Therapeutics Inc
04/29/20219:12AMInvestorsHub NewsWireRakovina Therapeutics Inc. Announces Inaugural Scientific Advisory BoardTSXV:RKVRakovina Therapeutics Inc
04/29/20216:00AMPR Newswire (Canada)Rakovina Therapeutics Inc. Announces Inaugural Scientific Advisory BoardTSXV:RKVRakovina Therapeutics Inc
04/08/202110:34AMInvestorsHub NewsWireRakovina Therapeutics Inc. Receives European and Canadian Patents on kt-2000 series PARP-inhibitorsTSXV:RKVRakovina Therapeutics Inc
04/08/20216:15AMPR Newswire (Canada)Rakovina Therapeutics Inc. Receives European and Canadian Patents on kt-2000 series PARP-inhibitorsTSXV:RKVRakovina Therapeutics Inc
04/05/20217:05PMPR Newswire (Canada)Rakovina Therapeutics Inc. Appoints Biotechnology Industry Veteran Julie M. Cherrington, PhD to Board of DirectorsTSXV:RKVRakovina Therapeutics Inc
04/01/20217:00AMPR Newswire (Canada)Rakovina Therapeutics Inc. Commences Trading on TSX Venture Exchange Under Ticker Symbol "RKV"TSXV:RKVRakovina Therapeutics Inc
 Showing the most relevant articles for your search:TSXV:RKV